Lundbeck
HLUN-B.CO
#2586
Rank
$5.47 B
Marketcap
$5.74
Share price
-1.88%
Change (1 day)
21.94%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Net assets

Net assets on the balance sheet as of September 2024 : $3.57 Billion USD

According to Lundbeck 's latest financial reports the company has $3.57 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Lundbeck - Net assets on balance sheet (from 2009 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$$3.26 B9.11%
2022-12-31$$2.99 B7.52%
2021-12-31$$2.78 B-0.81%
2020-12-31$$2.80 B11.5%
2019-12-31$$2.51 B15.24%
2018-12-31$$2.18 B11.19%
2017-12-31$$1.96 B43.07%
2016-12-31$$1.37 B6.61%
2015-12-31$$1.28 B-41.72%
2014-12-31$$2.20 B-11.49%
2013-12-31$$2.49 B6.65%
2012-12-31$$2.34 B5.15%
2011-12-31$$2.22 B12.13%
2010-12-31$$1.98 B17.05%
2009-12-31$$1.69 B20.23%
2008-12-31$$1.41 B0.31%
2007-12-31$$1.40 B17.22%
2006-12-31$$1.19 B1.12%
2005-12-31$$1.18 B-16.88%
2004-12-31$$1.42 B